Literature DB >> 30474162

Response to commentaries: The quest(ion) remains in the search for a meaningful reduction-based end-point.

Brian D Kiluk1, Garrett M Fitzmaurice2,3, Eric C Strain4, Roger D Weiss2,5.   

Abstract

Entities:  

Keywords:  Clinically meaningful outcome; DSM-5; functioning; negative consequences; substance use disorders; treatment end-point

Mesh：

Year:  2018        PMID： 30474162      PMCID： PMC6357767          DOI： 10.1111/add.14491

Source DB:  PubMed          Journal:  Addiction        ISSN： 0965-2140            Impact factor:   6.526


× No keyword cloud information.
  9 in total

1.  Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS).

Authors:  Bryce B Reeve; Ron D Hays; Jakob B Bjorner; Karon F Cook; Paul K Crane; Jeanne A Teresi; David Thissen; Dennis A Revicki; David J Weiss; Ronald K Hambleton; Honghu Liu; Richard Gershon; Steven P Reise; Jin-shei Lai; David Cella
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

2.  What defines a clinically meaningful outcome in the treatment of substance use disorders: 'Getting your life back'.

Authors:  Lara A Ray; Aaron C Lim; Steven Shoptaw
Journal:  Addiction       Date:  2018-11-13       Impact factor: 6.526

3.  Harm reduction in opioid treatment: an established idea under threat.

Authors:  Nicola J Kalk
Journal:  Addiction       Date:  2018-11-16       Impact factor: 6.526

4.  Don't ask apple trees to give pears.

Authors:  Anette Søgaard Nielsen
Journal:  Addiction       Date:  2018-08-16       Impact factor: 6.526

5.  Double standards and gold standards in the evaluation of how a person feels and functions in substance use disorder pharmacotherapy trials.

Authors:  Katie Witkiewitz
Journal:  Addiction       Date:  2018-09-11       Impact factor: 6.526

Review 6.  Medication development in opioid addiction: Meaningful clinical end points.

Authors:  Nora D Volkow; Janet Woodcock; Wilson M Compton; Douglas C Throckmorton; Phil Skolnick; Sharon Hertz; Eric M Wargo
Journal:  Sci Transl Med       Date:  2018-03-28       Impact factor: 17.956

Review 7.  DSM-5 criteria for substance use disorders: recommendations and rationale.

Authors:  Deborah S Hasin; Charles P O'Brien; Marc Auriacombe; Guilherme Borges; Kathleen Bucholz; Alan Budney; Wilson M Compton; Thomas Crowley; Walter Ling; Nancy M Petry; Marc Schuckit; Bridget F Grant
Journal:  Am J Psychiatry       Date:  2013-08       Impact factor: 18.112

8.  Change in DSM-5 Alcohol Use Disorder Criteria Count and Severity Level as a Treatment Outcome Indicator: Results from a Randomized Trial.

Authors:  Brian D Kiluk; Tami L Frankforter; Michelle Cusumano; Charla Nich; Kathleen M Carroll
Journal:  Alcohol Clin Exp Res       Date:  2018-06-05       Impact factor: 3.455

9.  What defines a clinically meaningful outcome in the treatment of substance use disorders: reductions in direct consequences of drug use or improvement in overall functioning?

Authors:  Brian D Kiluk; Garrett M Fitzmaurice; Eric C Strain; Roger D Weiss
Journal:  Addiction       Date:  2018-06-27       Impact factor: 6.526
  9 in total
  1 in total

1.  Characterizing cannabis use reduction and change in functioning during treatment: Initial steps on the path to new clinical endpoints.

Authors:  Jacob T Borodovsky; Michael J Sofis; Brian J Sherman; Kevin M Gray; Alan J Budney
Journal:  Psychol Addict Behav       Date:  2022-01-27
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.